Search Results - "Lioudaki, E."

Renal Effects of SGLT‐2 Inhibitors and Other Anti‐diabetic Drugs: Clinical Relevance and Potential Risks by Lioudaki, E, Whyte, M, Androulakis, ES, Stylianou, KG, Daphnis, EK, Ganotakis, ES

“…Type 2 diabetes mellitus (T2DM) is a metabolic disease affecting an increasing percentage of general population worldwide. Patients with T2DM are frequently…”
Get full text

POS-029 PATTERNS OF AKI IN PATIENTS HOSPITALISED WITH COVID-19 DURING THE FIRST WAVE OF THE COVID-19 PANDEMIC IN A LARGE UK TERTIARY CENTRE by JEWELL, P., Bramham, K., Smith, P., Kibble, H., Norton, S., Mudhaffer, A., Akter, M., Zuckerman, B., Palmer, K., Murphy, C., Iatropoulou, D., Sharpe, C., Lioudaki, E.

Get full text

Crescentic glomerulonephritis associated with vascular endothelial growth factor (VEGF) inhibitor and bisphosphonate administration by STYLIANOU, Kostas, LIOUDAKI, Eirini, PAPADIMITRAKI, Elisavet, KOKOLOGIANNAKIS, George, KROUSTALAKIS, Nikos, LIOTSI, Christina, GIANNAKAKIS, Konstantinos, GEORGOULIAS, Vasilios, DAPHNIS, Eugenios

“…Bevacizumab, a vascular endothelial growth factor (VEGF) inhibitor, has been widely used in a variety of malignancies offering substantial clinical benefit…”
Get full text